Laddar...

P11.05 LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

BACKGROUND: Lenalidomide is an immunomodulator agent that exhibits efficacy in multiple myeloma and haematological malignancies including refractory/relapsed diffuse large B-cell (DLBC) systemic lymphoma. METHODS: Retrospective review of PCNSL patients treated with lenalidomide at the Pitié-Salpêtri...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Houillier, C., Choquet, S., Touitou, V., Martin-Duverneuil, N., Hoang-Xuan, K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2014
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185581/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.228
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!